Breast cancer mortality after screening mammography in British Columbia women
- PMID: 17149701
- DOI: 10.1002/ijc.22249
Breast cancer mortality after screening mammography in British Columbia women
Abstract
Mammographic screening is a proven method for the early detection of breast cancer. The authors analyzed the impact of service mammographic screening on breast cancer mortality among British Columbia women who volunteered to be screened by the Screening Mammography Program of British Columbia. A cohort of women having at least one mammographic screen by Screening Mammography Program of British Columbia between the ages of 40 and 79 in the period 1988-2003 was identified. All cases and deaths from breast cancer occurring in British Columbia were identified from the British Columbia Cancer Registry and linked to the screening cohort. Expected deaths from breast cancer in the cohort were calculated using incidence and survival rates for British Columbia women not in the cohort. Adjustment was made for age and socioeconomic status of their area of residence at time of diagnosis. The breast cancer mortality ratio was calculated by dividing observed by expected breast cancer deaths. The mortality ratio (95% confidence interval) was 0.60 (0.55, 0.65) for all ages combined (p < 0.0001). The mortality ratio in women aged 40-49 at first screening was 0.61 (0.52, 0.71), similar to that in women over 50 (p = 0.90). Exclusion of mortality associated with breast cancers diagnosed after age 50 in women starting screening in their 40s increased the mortality ratio to 0.63 (0.52, 0.77), but it remained statistically significant. Correction for self-selection bias using estimates from the literature increased the mortality ratio for all ages to 0.76. Mammographic screening at all ages between 40 and 79 reduced subsequent mortality rates from breast cancer.
Copyright 2006 Wiley-Liss, Inc.
Comment in
-
Bias when calculating breast cancer mortality after screening mammography in British Colombia.Int J Cancer. 2007 Jun 1;120(11):2521; author reply 2522. doi: 10.1002/ijc.22623. Int J Cancer. 2007. PMID: 17311262 No abstract available.
Similar articles
-
Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia.J Med Screen. 2008;15(4):182-7. doi: 10.1258/jms.2008.008064. J Med Screen. 2008. PMID: 19106258
-
Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97.J Med Screen. 2000;7(3):152-9. doi: 10.1136/jms.7.3.152. J Med Screen. 2000. PMID: 11126165
-
Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.AJR Am J Roentgenol. 1994 May;162(5):1067-71; discussion 1072-5. doi: 10.2214/ajr.162.5.8165983. AJR Am J Roentgenol. 1994. PMID: 8165983
-
Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.J Med Screen. 2012;19 Suppl 1:33-41. doi: 10.1258/jms.2012.012080. J Med Screen. 2012. PMID: 22972809 Review.
-
Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294. APMIS. 2014. PMID: 25046200 Review.
Cited by
-
Temporal trends in the association between socioeconomic status and cancer survival in Ontario: a population-based retrospective study.CMAJ Open. 2017 Sep 6;5(3):E682-E689. doi: 10.9778/cmajo.20170025. CMAJ Open. 2017. PMID: 28877916 Free PMC article.
-
Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.Future Oncol. 2010 Apr;6(4):587-603. doi: 10.2217/fon.10.15. Future Oncol. 2010. PMID: 20373871 Free PMC article. Review.
-
Breast cancer distant recurrence lead time interval by detection method in an institutional cohort.BMC Cancer. 2020 Nov 20;20(1):1124. doi: 10.1186/s12885-020-07609-3. BMC Cancer. 2020. PMID: 33218313 Free PMC article.
-
Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.Med Oncol. 2013 Jun;30(2):471. doi: 10.1007/s12032-013-0471-5. Epub 2013 Feb 19. Med Oncol. 2013. PMID: 23420062 Review.
-
Benefits of screening mammography.JAMA. 2010 Jan 13;303(2):168-9. doi: 10.1001/jama.2009.1993. JAMA. 2010. PMID: 20068213 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical